The most quarterly R&D investment of Hanmi Pharmaceutical since it foundation
Hanmi Pharmaceutical is advancing on development of new global drugs as it continues the biggest quarterly investment since its foundation.
Hanmi Pharmaceutical made a public announcement that it put KRW 40.1 billion, which records the highest amount of money spent in a quarter, on the developme...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
